Dicerna Pharmaceuticals Inc. (DRNA) Declined -10.09% or -1.32 To Price $11.76 On Friday


Dicerna Pharmaceuticals Inc. (DRNA) declined -10.09% or -1.32 to $11.76. It is approximately 859527 shares traded, which is 117.76% compare to the average total volume 729913. The market cap of DRNA is $726.85 million. The year to date change is 29.65%. The 52 week price range is from $4.91 to $17.98. Price of DRNA have changed -1.13% during last week. It have changed -22.74% over last month, 3.81% over last 3 months, 24.69% over last 6 months and 148.20% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for DRNA is 15.16. It is 28.91% above current price. The 200-day Moving Averages for DRNA is 12.75. It is 8.42% above current price. The 52-week High is 17.98. It is 52.89% from the current price. The 52-week Low is 4.91. It is -58.25% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of DRNA is 5.14 on 2018-09-28. Short % to float is 7.38%. There are some statistics of DRNA. It is has market cap $726.85 million. The share outstanding is 61.81 million. The average volume is 729913. The revenue is 474000. The percent of top 15 Institution holding is 80.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of DRNA is -238.46%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of DRNA is -99.87%.


Tags:

Share this post